Tumor-associated lineage−CD45+CD33+ MDSCs from high-grade ovarian serous cancer patients suppress proliferation of T cells and inhibit their function through downregulating the expression of IL-2, INF-γ, and granzyme B, resulting in increased tumor volume [151]. The gene discussed is CD33; the disease is neoplasm.